These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 19639677)
41. Therapeutic advances and shift in disease paradigm for atopic dermatitis. Anstey A Br J Dermatol; 2008 Dec; 159(6):1215-6. PubMed ID: 19036027 [No Abstract] [Full Text] [Related]
42. Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. Mikhail M; Wolchok J; Goldberg SM; Dunkel IJ; Roses DF; Silverberg NB Arch Dermatol; 2008 Apr; 144(4):560-1. PubMed ID: 18427063 [No Abstract] [Full Text] [Related]
43. Topical tacrolimus (FK506) for the treatment of feline idiopathic facial dermatitis. Chung TH; Ryu MH; Kim DY; Yoon HY; Hwang CY Aust Vet J; 2009 Oct; 87(10):417-20. PubMed ID: 19796164 [TBL] [Abstract][Full Text] [Related]
49. [Topical tacrolimus in chronic actinic dermatitis]. Girault PY; Boye T; Veran Y Ann Dermatol Venereol; 2008 Oct; 135(10):688-90. PubMed ID: 18929923 [No Abstract] [Full Text] [Related]
50. [Silver for long-term topical application in atopic dermatitis]. Höger P Med Monatsschr Pharm; 2009 Sep; 32(9):350. PubMed ID: 19795698 [No Abstract] [Full Text] [Related]
51. [Are there any clinical evaluations confirming higher incidence of skin cancers as a result of pimecrolimus therapy?]. Barańjska-Rybak W; Nowicki R; Sokołowska-Wojdyło M; Roszkiewicz J Pol Merkur Lekarski; 2008 Sep; 25(147):284-7. PubMed ID: 19112851 [TBL] [Abstract][Full Text] [Related]
52. Management of atopic dermatitis: nonadherence to topical therapies in treatment of skin disease and the use of calcineurin inhibitors in difficult eczema. Anstey A Br J Dermatol; 2009 Aug; 161(2):219-20. PubMed ID: 19664122 [No Abstract] [Full Text] [Related]
53. Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. Wilson R; Camacho F; Clark AR; Young T; Inabinet R; Yentzer BA; Feldman SR J Am Acad Dermatol; 2009 Jan; 60(1):166-8. PubMed ID: 19103374 [No Abstract] [Full Text] [Related]
54. [Topical corticosteroids: how to use in clinical practice]. Furue M Arerugi; 2009 May; 58(5):491-8. PubMed ID: 19487829 [No Abstract] [Full Text] [Related]
56. Topical becaplermin: cancer. Think twice before using it. Prescrire Int; 2009 Apr; 18(100):68. PubMed ID: 19585725 [No Abstract] [Full Text] [Related]
57. Inhibition of contact allergy reactions by topical FK506. Lauerma AI; Maibach HI; Granlund H; Erkko P; Kartamaa M; Stubb S Lancet; 1992 Aug; 340(8818):556. PubMed ID: 1380111 [No Abstract] [Full Text] [Related]
58. Incontinentia pigmenti: treatment of IP with topical tacrolimus. Jessup CJ; Morgan SC; Cohen LM; Viders DE J Drugs Dermatol; 2009 Oct; 8(10):944-6. PubMed ID: 19852125 [TBL] [Abstract][Full Text] [Related]
59. Use of tacrolimus ointment in vitiligo alone or in combination therapy. Berti S; Buggiani G; Lotti T Skin Therapy Lett; 2009 May; 14(4):5-7. PubMed ID: 19585060 [TBL] [Abstract][Full Text] [Related]
60. Long-term prospective evaluation of topically applied 0.1% tacrolimus ointment for treatment of perianal sinuses in dogs. Stanley BJ; Hauptman JG J Am Vet Med Assoc; 2009 Aug; 235(4):397-404. PubMed ID: 19681720 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]